Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers

Gregory H. Taylor, Adrienne A. Williams, Alfredo Garzino-Demo

Research output: Contribution to journalArticle

Abstract

Increased levels of the proinflammatory cytokine IL-8 are detected in the sputum of patients with chronic obstructive pulmonary disease (COPD) and during the pathological pulmonary manifestations of HIV infection. To explore a potential interrelationship between smoking, highly active antiretroviral therapy (HAART) and HIV immune status, we collected sputum samples, along with complete pulmonary function tests from groups of HIV-infected women smokers who were either on or off HAART. Analysis of the patient's sputum for cell count along with quantitative measures of IL-8 was performed and correlated with concurrent assessment of pulmonary function test (PFT). We found that HIV-positive smokers had decreased measurements on PFT of the diffusing capacity of the lung for carbon monoxide (DLCO) compared to standard reference values that did not differ with HAART usage. HAART, when controlled for CD4, showed a suppressive effect on the levels of pro inflammatory cytokine IL-8 in sputum. We conclude that in the era of HAART, HIV along with concurrent tobacco smoking is associated with declines in PFT in HIV-infected women. The use of HAART in patients appears to mitigate the increases in IL-8 levels in relation to immune status based on CD4 count.

Original languageEnglish (US)
Article numberftv115
JournalPathogens and Disease
Volume74
Issue number2
DOIs
StatePublished - Mar 1 2016
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
Interleukin-8
Respiratory Function Tests
HIV
Sputum
Lung
Smoking
Cytokines
Lung Volume Measurements
Carbon Monoxide
CD4 Lymphocyte Count
Chronic Obstructive Pulmonary Disease
HIV Infections
Reference Values
Cell Count

Keywords

  • Antiretroviral therapy
  • HIV
  • IL-8
  • Pulmonary function
  • Smoking
  • Tobacco

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers. / Taylor, Gregory H.; Williams, Adrienne A.; Garzino-Demo, Alfredo.

In: Pathogens and Disease, Vol. 74, No. 2, ftv115, 01.03.2016.

Research output: Contribution to journalArticle

Taylor, Gregory H. ; Williams, Adrienne A. ; Garzino-Demo, Alfredo. / Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers. In: Pathogens and Disease. 2016 ; Vol. 74, No. 2.
@article{e89da7cf501b4c3aa512d20358762673,
title = "Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers",
abstract = "Increased levels of the proinflammatory cytokine IL-8 are detected in the sputum of patients with chronic obstructive pulmonary disease (COPD) and during the pathological pulmonary manifestations of HIV infection. To explore a potential interrelationship between smoking, highly active antiretroviral therapy (HAART) and HIV immune status, we collected sputum samples, along with complete pulmonary function tests from groups of HIV-infected women smokers who were either on or off HAART. Analysis of the patient's sputum for cell count along with quantitative measures of IL-8 was performed and correlated with concurrent assessment of pulmonary function test (PFT). We found that HIV-positive smokers had decreased measurements on PFT of the diffusing capacity of the lung for carbon monoxide (DLCO) compared to standard reference values that did not differ with HAART usage. HAART, when controlled for CD4, showed a suppressive effect on the levels of pro inflammatory cytokine IL-8 in sputum. We conclude that in the era of HAART, HIV along with concurrent tobacco smoking is associated with declines in PFT in HIV-infected women. The use of HAART in patients appears to mitigate the increases in IL-8 levels in relation to immune status based on CD4 count.",
keywords = "Antiretroviral therapy, HIV, IL-8, Pulmonary function, Smoking, Tobacco",
author = "Taylor, {Gregory H.} and Williams, {Adrienne A.} and Alfredo Garzino-Demo",
year = "2016",
month = "3",
day = "1",
doi = "10.1093/femspd/ftv115",
language = "English (US)",
volume = "74",
journal = "Pathogens and Disease",
issn = "2049-632X",
publisher = "John Wiley & Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers

AU - Taylor, Gregory H.

AU - Williams, Adrienne A.

AU - Garzino-Demo, Alfredo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Increased levels of the proinflammatory cytokine IL-8 are detected in the sputum of patients with chronic obstructive pulmonary disease (COPD) and during the pathological pulmonary manifestations of HIV infection. To explore a potential interrelationship between smoking, highly active antiretroviral therapy (HAART) and HIV immune status, we collected sputum samples, along with complete pulmonary function tests from groups of HIV-infected women smokers who were either on or off HAART. Analysis of the patient's sputum for cell count along with quantitative measures of IL-8 was performed and correlated with concurrent assessment of pulmonary function test (PFT). We found that HIV-positive smokers had decreased measurements on PFT of the diffusing capacity of the lung for carbon monoxide (DLCO) compared to standard reference values that did not differ with HAART usage. HAART, when controlled for CD4, showed a suppressive effect on the levels of pro inflammatory cytokine IL-8 in sputum. We conclude that in the era of HAART, HIV along with concurrent tobacco smoking is associated with declines in PFT in HIV-infected women. The use of HAART in patients appears to mitigate the increases in IL-8 levels in relation to immune status based on CD4 count.

AB - Increased levels of the proinflammatory cytokine IL-8 are detected in the sputum of patients with chronic obstructive pulmonary disease (COPD) and during the pathological pulmonary manifestations of HIV infection. To explore a potential interrelationship between smoking, highly active antiretroviral therapy (HAART) and HIV immune status, we collected sputum samples, along with complete pulmonary function tests from groups of HIV-infected women smokers who were either on or off HAART. Analysis of the patient's sputum for cell count along with quantitative measures of IL-8 was performed and correlated with concurrent assessment of pulmonary function test (PFT). We found that HIV-positive smokers had decreased measurements on PFT of the diffusing capacity of the lung for carbon monoxide (DLCO) compared to standard reference values that did not differ with HAART usage. HAART, when controlled for CD4, showed a suppressive effect on the levels of pro inflammatory cytokine IL-8 in sputum. We conclude that in the era of HAART, HIV along with concurrent tobacco smoking is associated with declines in PFT in HIV-infected women. The use of HAART in patients appears to mitigate the increases in IL-8 levels in relation to immune status based on CD4 count.

KW - Antiretroviral therapy

KW - HIV

KW - IL-8

KW - Pulmonary function

KW - Smoking

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=84997403826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997403826&partnerID=8YFLogxK

U2 - 10.1093/femspd/ftv115

DO - 10.1093/femspd/ftv115

M3 - Article

C2 - 26656889

AN - SCOPUS:84997403826

VL - 74

JO - Pathogens and Disease

JF - Pathogens and Disease

SN - 2049-632X

IS - 2

M1 - ftv115

ER -